NCT07485309

Brief Summary

This prospective randomized controlled trial compares periareolar excision and pull-through techniques in 64 patients with Simon Grade I-IIb gynecomastia. Patients were randomized 1:1 and followed for 6 months. The primary outcome was total patient satisfaction measured using the Rasch-transformed BODY-Q Chest Module. Secondary outcomes included anthropometric measurements, recovery parameters, complication rates, and blinded aesthetic evaluation. A formal interaction analysis assessed whether surgical superiority differed according to disease severity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 12, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 20, 2026

Completed
Last Updated

March 20, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

March 12, 2026

Last Update Submit

March 16, 2026

Conditions

Keywords

Gynecomastia SurgeryPeriareolar ExcisionPull-through TechniqueSimon ClassificationBODY-QChest Contouring

Outcome Measures

Primary Outcomes (1)

  • Total Patient Satisfaction (BODY-Q Chest Module)

    Patient-reported satisfaction with chest appearance measured using the Rasch-transformed BODY-Q Chest Module questionnaire. Higher scores indicate greater satisfaction following gynecomastia surgery.

    6 months postoperative

Secondary Outcomes (7)

  • Domain-level BODY-Q Scores

    6 months postoperative

  • Change in Chest Anthropometric Measurements

    Preoperative and 6 months postoperative

  • Number of Participants With Postoperative Complications

    Within 6 months postoperative

  • Length of Postoperative Hospital Stay

    Within 30 days postoperative

  • Postoperative Pain Score

    Postoperative day 1

  • +2 more secondary outcomes

Study Arms (2)

Periareolar Excision

ACTIVE COMPARATOR

Participants undergo gynecomastia correction using a semicircular inferior periareolar incision allowing direct glandular excision following liposuction. A thin subareolar tissue layer is preserved to prevent nipple depression.

Procedure: Periareolar Excision

Pull-Through Technique

ACTIVE COMPARATOR

Participants undergo minimally invasive gynecomastia correction using liposuction followed by glandular extraction through the liposuction incision using the pull-through technique with controlled traction and segmental excision.

Procedure: Pull-Through Technique

Interventions

Surgical correction of gynecomastia using a semicircular inferior periareolar incision to allow direct glandular excision following liposuction. A thin subareolar tissue layer is preserved to prevent nipple depression and maintain contour.

Periareolar Excision

Minimally invasive surgical correction of gynecomastia using liposuction followed by glandular extraction through the liposuction incision using the pull-through technique with controlled traction and segmental excision.

Pull-Through Technique

Eligibility Criteria

Age18 Years - 50 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male patients aged 18 to 50 years
  • Clinically diagnosed Simon Grade I-IIb gynecomastia
  • Persistent gynecomastia for more than 18 months
  • Candidates for surgical correction under general anesthesia
  • Provided written informed consent to participate in the study

You may not qualify if:

  • Simon Grade III gynecomastia requiring skin excision
  • Gynecomastia secondary to untreated endocrine disorders
  • Chronic hepatic or renal disease
  • Suspected or confirmed breast malignancy
  • Previous gynecomastia surgery
  • Active infection
  • Coagulopathy or bleeding disorders
  • Contraindications to general anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kafr El-Sheikh University Hospital

Kafr ash Shaykh, Kafr el-Sheikh Governorate, 33516, Egypt

Location

MeSH Terms

Conditions

Gynecomastia

Condition Hierarchy (Ancestors)

Breast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • asem Elkot, MD

    Plastic Surgery Department, Faculty of Medicine, Kafr El-Sheikh University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants were blinded to the surgical technique performed. Postoperative aesthetic outcomes were evaluated using standardized photographs assessed by independent board-certified plastic surgeons who were blinded to treatment allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants with Simon Grade I-IIb gynecomastia were randomized in a 1:1 ratio to undergo either periareolar excision or pull-through technique. Outcomes were compared between parallel groups over a 6-month follow-up period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of general surgery department

Study Record Dates

First Submitted

March 12, 2026

First Posted

March 20, 2026

Study Start

September 1, 2024

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

March 20, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be publicly shared. Data may be available from the corresponding investigator upon reasonable request and with appropriate institutional approval.

Locations